Biblio

Export 1335 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is P  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
M. A. Mukhamedyarov, Rizvanov, A. A., Yakupov, E. Z., Zefirov, A. L., Kiyasov, A. P., Reis, H. J., Teixeira, A. L., Vieira, L. B., Lima, L. M., Salafutdinov, I. I., Petukhova, E. O., Khaiboullina, S. F., Schlauch, K. A., Lombardi, V. C., and Palotás, A., “Transcriptional Analysis of Blood Lymphocytes and Skin Fibroblasts, Keratinocytes, and Endothelial Cells as a Potential Biomarker for Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1373-1383, 2016.
I. S. Piras, Krate, J., Delvaux, E., Nolz, J., Mastroeni, D. F., Persico, A. M., Jepsen, W. M., Beach, T. G., Huentelman, M. J., and Coleman, P. D., “Transcriptome Changes in the Alzheimer's Disease Middle Temporal Gyrus: Importance of RNA Metabolism and Mitochondria-Associated Membrane Genes.”, J Alzheimers Dis, vol. 70, no. 3, pp. 691-713, 2019.
I. S. Piras, Krate, J., Delvaux, E., Nolz, J., Mastroeni, D. F., Persico, A. M., Jepsen, W. M., Beach, T. G., Huentelman, M. J., and Coleman, P. D., “Transcriptome Changes in the Alzheimer's Disease Middle Temporal Gyrus: Importance of RNA Metabolism and Mitochondria-Associated Membrane Genes.”, J Alzheimers Dis, vol. 70, no. 3, pp. 691-713, 2019.
S. D. Portbury, Hare, D. J., Sgambelloni, C., Perronnes, K., Portbury, A. J., Finkelstein, D. I., and Adlard, P. A., “Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 549-560, 2017.
S. D. Portbury, Hare, D. J., Sgambelloni, C., Perronnes, K., Portbury, A. J., Finkelstein, D. I., and Adlard, P. A., “Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 549-560, 2017.
S. D. Portbury, Hare, D. J., Sgambelloni, C., Perronnes, K., Portbury, A. J., Finkelstein, D. I., and Adlard, P. A., “Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 549-560, 2017.
R. Guerreiro, Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J. - C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., and Hardy, J., “TREM2 variants in Alzheimer's disease.”, N Engl J Med, vol. 368, no. 2, pp. 117-27, 2013.
R. Guerreiro, Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J. - C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., and Hardy, J., “TREM2 variants in Alzheimer's disease.”, N Engl J Med, vol. 368, no. 2, pp. 117-27, 2013.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
F. Pasquier, Sadowsky, C., Holstein, A., Leterme, G. Le Prince, Peng, Y., Jackson, N., Fox, N. C., Ketter, N., Liu, E., and J Ryan, M., “Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1131-43, 2016.
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., “Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
T. Rognoni, Fernández-Matarrubia, M., Martínez-González, M. Ángel, Salas-Salvadó, J., Corella, D., Castañer, O., J Martínez, A., Alonso-Gómez, Á. M., Gómez-Gracia, E., Vioque, J., Romaguera, D., López-Miranda, J., Estruch, R., Tinahones, F. J., Santos-Lozano, J. Manuel, Serra-Majem, L., Ibañez, N. Cano, Tur, J. A., Pérez, R. Micó, Pintó, X., Delgado-Rodríguez, M., Ramos, M. Ortiz, Martín, J. Vidal, Vázquez, C., Daimiel, L., Ros, E., Goñi-Ruiz, N., Babio, N., Sorlí, J. V., Schröder, H., García-Rios, A., Compañ-Gabucio, L., Warnberg, J., M Zulet, Á., Chaplin, A., Sacanella, E., Bouzalmate-Hajjaj, A., Tojal-Sierra, L., Damas-Fuentes, M., Vázquez, Z., Gómez-Martínez, C., Saiz, C., Malcampo, M., Ortiz-Morales, A. M., Martínez-Avilés, V., García-Gavilan, J., Abete, I., Fitó, M., and Toledo, E., “Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome.”, J Alzheimers Dis, vol. 95, no. 3, pp. 887-899, 2023.
T. Rognoni, Fernández-Matarrubia, M., Martínez-González, M. Ángel, Salas-Salvadó, J., Corella, D., Castañer, O., J Martínez, A., Alonso-Gómez, Á. M., Gómez-Gracia, E., Vioque, J., Romaguera, D., López-Miranda, J., Estruch, R., Tinahones, F. J., Santos-Lozano, J. Manuel, Serra-Majem, L., Ibañez, N. Cano, Tur, J. A., Pérez, R. Micó, Pintó, X., Delgado-Rodríguez, M., Ramos, M. Ortiz, Martín, J. Vidal, Vázquez, C., Daimiel, L., Ros, E., Goñi-Ruiz, N., Babio, N., Sorlí, J. V., Schröder, H., García-Rios, A., Compañ-Gabucio, L., Warnberg, J., M Zulet, Á., Chaplin, A., Sacanella, E., Bouzalmate-Hajjaj, A., Tojal-Sierra, L., Damas-Fuentes, M., Vázquez, Z., Gómez-Martínez, C., Saiz, C., Malcampo, M., Ortiz-Morales, A. M., Martínez-Avilés, V., García-Gavilan, J., Abete, I., Fitó, M., and Toledo, E., “Two-Year Changes in Physical Activity and Concurrent Changes in Cognitive Function in a Cohort of Adults with Metabolic Syndrome.”, J Alzheimers Dis, vol. 95, no. 3, pp. 887-899, 2023.
U
K. Muthukumaran, Kanwar, A., Vegh, C., Marginean, A., Elliott, A., Guilbeault, N., Badour, A., Sikorska, M., Cohen, J., and Pandey, S., “Ubisol-Q10 (a Nanomicellar Water-Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 221-236, 2018.
E. Tuzzi, Balla, D. Z., Loureiro, J. R. A., Neumann, M., Laske, C., Pohmann, R., Preische, O., Scheffler, K., and Hagberg, G. E., “Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
E. Tuzzi, Balla, D. Z., Loureiro, J. R. A., Neumann, M., Laske, C., Pohmann, R., Preische, O., Scheffler, K., and Hagberg, G. E., “Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
P. Chatterjee, Elmi, M., Goozee, K., Shah, T., Sohrabi, H. R., Dias, C. B., Pedrini, S., Shen, K., Asih, P. R., Dave, P., Taddei, K., Vanderstichele, H., Zetterberg, H., Blennow, K., and Martins, R. N., “Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 3, pp. 775-783, 2019.
H. - S. Yang, Chhatwal, J. P., Xu, J., White, C. C., Hanseeuw, B., Rabin, J. S., Papp, K. V., Buckley, R. F., Schultz, A. P., Properzi, M. J., Gatchel, J. R., Amariglio, R. E., Donovan, N. J., Mormino, E. C., Hedden, T., Marshall, G. A., Rentz, D. M., Johnson, K. A., De Jager, P. L., and Sperling, R. A., “An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults.”, J Alzheimers Dis, vol. 68, no. 3, pp. 1161-1170, 2019.
H. - S. Yang, Chhatwal, J. P., Xu, J., White, C. C., Hanseeuw, B., Rabin, J. S., Papp, K. V., Buckley, R. F., Schultz, A. P., Properzi, M. J., Gatchel, J. R., Amariglio, R. E., Donovan, N. J., Mormino, E. C., Hedden, T., Marshall, G. A., Rentz, D. M., Johnson, K. A., De Jager, P. L., and Sperling, R. A., “An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults.”, J Alzheimers Dis, vol. 68, no. 3, pp. 1161-1170, 2019.
N. Dermody, Wong, S., Ahmed, R., Piguet, O., Hodges, J. R., and Irish, M., “Uncovering the Neural Bases of Cognitive and Affective Empathy Deficits in Alzheimer's Disease and the Behavioral-Variant of Frontotemporal Dementia.”, J Alzheimers Dis, vol. 53, no. 3, pp. 801-16, 2016.
I. Santana, Baldeiras, I., Santiago, B., Duro, D., Freitas, S., Pereira, M. Tábuas, Almeida, M. Rosário, and Oliveira, C. Resende, “Underlying Biological Processes in Mild Cognitive Impairment: Amyloidosis Versus Neurodegeneration.”, J Alzheimers Dis, vol. 64, no. s1, pp. S647-S657, 2018.
C. Griñán-Ferré, Corpas, R., Puigoriol-Illamola, D., Palomera-Ávalos, V., Sanfeliu, C., and Pallas, M., “Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.”, J Alzheimers Dis, vol. 62, no. 3, pp. 943-963, 2018.
C. Griñán-Ferré, Corpas, R., Puigoriol-Illamola, D., Palomera-Ávalos, V., Sanfeliu, C., and Pallas, M., “Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.”, J Alzheimers Dis, vol. 62, no. 3, pp. 943-963, 2018.
C. Griñán-Ferré, Corpas, R., Puigoriol-Illamola, D., Palomera-Ávalos, V., Sanfeliu, C., and Pallas, M., “Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.”, J Alzheimers Dis, vol. 62, no. 3, pp. 943-963, 2018.
G. Paroni, Bisceglia, P., and Seripa, D., “Understanding the Amyloid Hypothesis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 2, pp. 493-510, 2019.

Pages